Home › Funds › JTC Employer Solutions Trustee Ltd › GSK

JTC Employer Solutions Trustee Ltd position in GSK

GSK PLC · Health Care

JTC Employer Solutions Trustee Ltd reported holding 8,077,477 shares of GSK (GSK PLC) in its Q3 2026 13F filing — a position valued at US$389.2M, representing 33.51% of its reported portfolio and ranking #1 among its reported holdings. JTC Employer Solutions Trustee Ltd has disclosed GSK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)8.08M sh
Reported value held$389.17M
Portfolio Weight33.51%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How JTC Employer Solutions Trustee Ltd's GSK position evolved

JTC Employer Solutions Trustee Ltd first disclosed a stake in GSK in Q3 2023 at 12,444,460 shares (US$451.1M). The position peaked in Q1 2024 at 21,141,012 shares, worth US$909.1M. Across 13 filings, JTC Employer Solutions Trustee Ltd increased the stake 1 time(s), trimmed it 11 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 8,077,477 shares valued at US$389.2M — a reduction of -515,510 shares quarter over quarter.. Notable position changes include a 71% increase in Q1 2024 (shares fell 10% over the following quarter), a 37% trim in Q1 2026 (shares fell 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 12.44M $451.11M New
Q4 2023 12.34M $457.76M Reduce
Q1 2024 21.14M $909.06M Add
Q2 2024 20.88M $803.79M Reduce
Q3 2024 20.48M $837.36M Reduce
Q4 2024 20.28M $682.27M Reduce
Q1 2025 15.26M $591.57M Reduce
Q2 2025 15.00M $575.67M Reduce
Q3 2025 14.60M $629.94M Reduce
Q4 2025 14.43M $707.69M Reduce
Q1 2026 9.04M $498.91M Reduce
Q2 2026 8.59M $450.31M Reduce
Q3 2026 8.08M $389.17M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GSK and 13F data

GSK (GSK PLC) is a Health Care company. 19 other funds we track also report a position in GSK — the largest reported positions include Dodge & Cox (US$2.53B), DODGE & COX (US$2.53B), PRIMECAP MANAGEMENT CO/CA/ (US$1.21B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GSK

All GSK fund holders →

FAQ

How long has JTC Employer Solutions Trustee Ltd held GSK?

JTC Employer Solutions Trustee Ltd has disclosed GSK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is JTC Employer Solutions Trustee Ltd's current position in GSK?

As of Q3 2026, JTC Employer Solutions Trustee Ltd holds 8.08M shares of GSK (GSK PLC), valued at $389.17M, representing 33.51% of its reported portfolio and ranking #1.

Has JTC Employer Solutions Trustee Ltd been buying or selling GSK?

In the latest 13F filing (Q3 2026), JTC Employer Solutions Trustee Ltd reduced its position in GSK. The position peaked in Q1 2024 at 21.14M shares.

Which other funds hold GSK?

Other major institutional holders of GSK include Dodge & Cox, DODGE & COX, PRIMECAP MANAGEMENT CO/CA/, among 19 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.